Measuring tumor metabolism by 18F-FDG PET predicts outcome in a multicenter study: a step off in the right direction.
Overview
publication date
- January 1, 2015
published in
Research
keywords
- Antineoplastic Agents
- Breast Neoplasms
- Fluorodeoxyglucose F18
- Positron-Emission Tomography
- Receptor, ErbB-2
Identity
Scopus Document Identifier
- 84920417232
Digital Object Identifier (DOI)
- 10.2967/jnumed.114.151175
PubMed ID
- 25537988
Additional Document Info
has global citation frequency
volume
- 56
issue
- 1